Health Care & Life Sciences » Biotechnology | Loxo Oncology Inc.

Loxo Oncology Inc.

Loxo Oncology Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
30.47 M
Public Float
21.8 M
Loxo Oncology Inc.
Stock Exchange NASDAQ Stock Market
EPS
$3.65
Market Cap
$5.2 B
Shares Outstanding
30.47 M
Public Float
27.26 M

Profile

Address
281 Tresser Boulevard
Stamford Connecticut 06901
United States
Employees -
Website http://www.loxooncology.com
Updated 09/14/2018
Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H.

Financials

View All

Joshua H. Bilenker
President, Chief Executive Officer & Director
Keith T. Flaherty
Director